AU5359186A - Method & product for enhancing circulating antibody response - Google Patents

Method & product for enhancing circulating antibody response

Info

Publication number
AU5359186A
AU5359186A AU53591/86A AU5359186A AU5359186A AU 5359186 A AU5359186 A AU 5359186A AU 53591/86 A AU53591/86 A AU 53591/86A AU 5359186 A AU5359186 A AU 5359186A AU 5359186 A AU5359186 A AU 5359186A
Authority
AU
Australia
Prior art keywords
product
antibody response
circulating antibody
enhancing circulating
enhancing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53591/86A
Inventor
Chin Chuan Chang
Harold A. Nash
Yun-Yen Tsong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Population Council Inc
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Publication of AU5359186A publication Critical patent/AU5359186A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU53591/86A 1985-01-25 1986-01-24 Method & product for enhancing circulating antibody response Abandoned AU5359186A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US69479885A 1985-01-25 1985-01-25
US694798 1985-01-25
US82016386A 1986-01-21 1986-01-21
US820163 1986-01-21

Publications (1)

Publication Number Publication Date
AU5359186A true AU5359186A (en) 1986-08-13

Family

ID=27105440

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53591/86A Abandoned AU5359186A (en) 1985-01-25 1986-01-24 Method & product for enhancing circulating antibody response

Country Status (3)

Country Link
EP (1) EP0211045A1 (en)
AU (1) AU5359186A (en)
WO (1) WO1986004243A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2849632B2 (en) * 1988-04-08 1999-01-20 社団法人北里研究所 Vaccine preparation
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1132676A (en) * 1966-03-08 1968-11-06 Chugai Pharmaceutical Co Ltd Anti-tumour preparation and process for preparing the same

Also Published As

Publication number Publication date
EP0211045A1 (en) 1987-02-25
WO1986004243A1 (en) 1986-07-31

Similar Documents

Publication Publication Date Title
AU627428B2 (en) Packaging system & method
AU567952B2 (en) Labelled nucleic acid probes
AU587159B2 (en) System for identifying particular objects
AU1480388A (en) Altered antibodies
AU3832985A (en) Assay for nucleic acids
AU556063B2 (en) Non centrifugation method for immunoassay
AU561529B2 (en) Plasmodium antigen
GB8624797D0 (en) Thermoelectrochemical system & method
GB8815869D0 (en) Emulsion paint & method for its manufacture
AU553983B2 (en) Aluminium treated proteins
GB8505487D0 (en) Antibodies
AU569816B2 (en) Monoclonal anti-alpha-amylase antibody
GR862208B (en) 6-phenoxymethyl-4-hydroxytetrahydropyran-2-one method for its preparation
AU6659686A (en) Modified solid supports for immunoassays
AU6132586A (en) Heatpacks for food
AU580604B2 (en) Coil forming method
AU5359186A (en) Method & product for enhancing circulating antibody response
AU8069787A (en) Insect-proofing method
AU584067B2 (en) Lift guidance system
AU5647886A (en) Improved method for determining mimotopes
AU5689286A (en) Process
AU6961087A (en) Novel method
AU530851B3 (en) Assay method for tsh
AU568976B2 (en) Combination weighing method
HUT41905A (en) Method for indicating antibodies